Royal Bank of Canada’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $333K | Sell |
|
|||||
|
2025
Q2 | $2.03M | Buy |
|
|||||
|
2025
Q1 | $1.42M | Buy |
|
|||||
|
2024
Q4 | $250K | Sell |
|
|||||
|
2024
Q3 | $299K | Sell |
|
|||||
|
2024
Q2 | $373K | Buy |
|
|||||
|
2024
Q1 | $155K | Sell |
|
|||||
|
2023
Q4 | $336K | Buy |
|
|||||
|
2023
Q3 | $200K | Buy |
|
|||||
|
2023
Q2 | $108K | Buy |
|
|||||
|
2023
Q1 | $53K | Sell |
|
|||||
|
2022
Q4 | $172K | Buy |
|
|||||
|
2022
Q3 | $21K | Buy |
|
|||||
|
2022
Q2 | $8K | Sell |
|
|||||
|
2022
Q1 | $51K | Sell |
|
|||||
|
2021
Q4 | $425K | Buy |
|
|||||
|
2021
Q3 | $65K | Buy |
|
|||||
|
2021
Q2 | $53K | Buy |
|